PFE Market Cap Falls More Than $7B in a Month: How to Play the Stock

Pfizer PFE stock has declined almost 5% in a month, losing $7.3 billion in market capitalization. Shares dipped recently ...

Pfizer's Patent Cliff, Rising Debt, And The Fight To Stay A Buy

Pfizer is a Buy at low valuation but faces a 2030 patent cliff, COVID sales declines, and LOE risks. Click here to read an ...

Analysis Finds Most Pharmaceutical Price Changes Modest Despite Notable Outliers

FAYETTEVILLE, NY, UNITED STATES, January 7, 2026 /EINPresswire.com/ — January is traditionally a peak period for pharmaceutical list price adjustments. The AnalySource team analyzed Wholesale ...
BC Technology

Acuitas Therapeutics Acquires Majority Stake in Montreal's RNA Technologies & Therapeutics Through Strategic Investment

Acuitas Therapeutics, a leader in lipid nanoparticle (LNP) delivery systems for nucleic acid therapeutics, announced that it ...
Malaysia Sun

Drugmakers face fresh legal challenge over vaccine technology

Bayer has opened a new legal front in the long-running battles over COVID-19 vaccine technology, suing several major ...